» Articles » PMID: 30768215

Quantification of Retinal Nonperfusion Associated With Posterior Segment Neovascularization in Diabetic Retinopathy Using Ultra-Widefield Fluorescein Angiography

Overview
Date 2019 Feb 16
PMID 30768215
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objective: To quantify the size and location of nonperfusion associated with posterior segment neovascularization (NV) in proliferative diabetic retinopathy (PDR) using ultra-widefield fluorescein angiography.

Patients And Methods: Cross-sectional study of 18 eyes with PDR. The total image area, areas of nonperfusion, buds of posterior segment neovascularization (either neovascularization of the disc or elsewhere), and the distances from each bud to the nearest area of nonperfusion and to the disc were measured.

Results: Nonperfused areas with associated neovascularization were significantly larger than areas without neovascularization (32.0% ± 5.24% of the retinal image vs. 3.3% ± 0.92%; P < .001) and were more likely to be posteriorly located. Nonperfusion encompassing greater than 23% of the total angiographic image had more associated neovascular buds (9.64 ± 2.16 vs. 0.86 ± 0.29; P < .0001), which were closer to the disc (7.53 mm ± 0.27 mm vs. 9.24 mm ± 0.64 mm; P = .014).

Conclusion: A threshold size of nonperfusion greater than 23% of the retinal image is associated with posterior segment neovascularization and may serve as an indicator of risk for the development of PDR. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:86-92.].

Citing Articles

Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study.

Wang W, Spiegelman D, Rao P, Rhee R, Ford A, Miner J J Clin Invest. 2024; 134(12).

PMID: 38950286 PMC: 11178534. DOI: 10.1172/JCI180916.


Progress in clinical research and applications of retinal vessel quantification technology based on fundus imaging.

Chen N, Zhu Z, Yang W, Wang Q Front Bioeng Biotechnol. 2024; 12:1329263.

PMID: 38456011 PMC: 10917897. DOI: 10.3389/fbioe.2024.1329263.


Peripheral and central capillary non-perfusion in diabetic retinopathy: An updated overview.

Antropoli A, Arrigo A, La Franca L, Bianco L, Barlocci E, Fusi E Front Med (Lausanne). 2023; 10:1125062.

PMID: 37035306 PMC: 10076599. DOI: 10.3389/fmed.2023.1125062.


Clinical significance of metabolic quantification for retinal nonperfusion in diabetic retinopathy.

Jeong A, Yao X, van Hemert J, Sagong M Sci Rep. 2022; 12(1):9342.

PMID: 35665762 PMC: 9167306. DOI: 10.1038/s41598-022-13439-z.


Effect of anti-VEGF treatment on nonperfusion areas in ischemic retinopathy.

Zhu Z, Meng Y, Yan B, Luo J Int J Ophthalmol. 2021; 14(11):1647-1652.

PMID: 34804852 PMC: 8569571. DOI: 10.18240/ijo.2021.11.01.


References
1.
Klein R, Knudtson M, Lee K, Gangnon R, Klein B . The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009; 116(3):497-503. PMC: 2693093. DOI: 10.1016/j.ophtha.2008.10.016. View

2.
Kaines A, Oliver S, Reddy S, Schwartz S . Ultrawide angle angiography for the detection and management of diabetic retinopathy. Int Ophthalmol Clin. 2009; 49(2):53-9. DOI: 10.1097/IIO.0b013e31819fd471. View

3.
Oliver S, Schwartz S . Peripheral vessel leakage (PVL): a new angiographic finding in diabetic retinopathy identified with ultra wide-field fluorescein angiography. Semin Ophthalmol. 2010; 25(1-2):27-33. DOI: 10.3109/08820538.2010.481239. View

4.
. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991; 98(5 Suppl):766-85. View

5.
Wessel M, Aaker G, Parlitsis G, Cho M, DAmico D, Kiss S . Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina. 2011; 32(4):785-91. DOI: 10.1097/IAE.0b013e3182278b64. View